Background. Amoebic keratitis is a potentially blinding eye infection caused by ubiquitous, free-living, environmental acanthamoebae, which are known to harbor bacterial endosymbionts. A Chlamydia-like endosymbiont has previously enhanced Acanthamoeba virulence in vitro. We investigated the potential effect of Acanthamoeba-endosymbiont coinfection in a human corneal tissue model representing clinical amoebic keratitis infection.
Amoebic keratitis (AK) is a potentially blinding eye infection caused by free-living amoebae of the genus Acanthamoeba, which are ubiquitous, free-living organisms [1] . AK usually occurs in the context of contact lens use, and outbreaks have been linked to contact lens solutions contaminated with acanthamoebae, including the most recent outbreak in the United States, which affected 138 persons and led to the recall of several contact lens solutions by both the Food and Drug Administration (FDA) and Health Canada [2] . Despite considerable investigation into various treatment approaches, 6-12-month courses of biguanides remain the mainstay of treatment [3] , with keratoplasty being required in >25% of cases [4] . Thus, novel treatment approaches are required to reduce AK-associated morbidity.
Acanthamoebae isolated from the environment and from the corneas of patients with AK harbor bacterial endosymbionts belonging to the Chlamydiales, Rickettsiales, and Legionellales [5] [6] [7] [8] . Many of these organisms are related to known oculotropic pathogens [9] [10] [11] suggesting that endosymbionts may play a role in the pathogenesis of AK. Previous studies demonstrated that a Chlamydia-like endosymbiont enhanced Acanthamoeba virulence in vitro [12] , and Fritsche et al [5] demonstrated that supplementation of Acanthamoeba with endosymbiotic prokaryotes enhanced cytopathic effects (CPEs) on a fibroblast monolayer; however, it is unclear whether this endosymbiosis translates to a significant effect in vivo. Current AK antimicrobial chemotherapy targets the eukaryotic Acanthamoeba and therefore has a negligible effect on prokaryotes, especially ones that are intracellular. If bacterial endosymbionts contribute to enhanced virulence in AK, then directing antimicrobial therapy against such endosymbionts may attenuate infection. Such an approach could enable shortened treatment courses of FDA-approved antimicrobials, limit corneal damage, and reduce the need for keratoplasty.
The MatTek EpiCorneal tissue model consists of human corneal cells that are cultured on a synthetic microporous membrane. The cells form a stratified squamous epithelium that closely parallels human corneal epithelial tissue, including expression of tight junctions, cornea-specific drug transporters, and enzymes. Similar models have been used previously to assess the effect of chemical irritants and pharmaceuticals on the cornea [13] . We sought to elucidate the effect of Acanthamoebaendosymbiont coinfection in the MatTek 3D human corneal tissue model, representing a clinical AK infection. We screened American Type Culture Collection (ATCC) strains of Acanthamoeba for potential endosymbionts and then examined the contribution of such potential endosymbionts to observed CPE and inflammatory biomarker production. Finally, we determined how the addition of azithromycin or doxycycline to the corneal tissue model of AK affected CPE and biomarker end points. We selected azithromycin and doxycycline because they are effective antimicrobials against intracellular bacteria, have been used previously in the treatment of ocular disease [14] , and have a long record of safety in humans. Moreover, azithromycin and doxycycline have demonstrated efficacy in the treatment of Chlamydiales [15] , Rickettsiales [16, 17] , and Legionellales [18, 19] .
MATERIALS AND METHODS

Acanthamoeba Strains
All Acanthamoeba strains used in this study were obtained from the ATCC (Table 1) . Strains were cultured axenically at 25°C in ATCC medium 712 peptone-yeast-glucose (PYG), with additives prepared as directed by the manufacturer. Each culture was examined for the presence of any extracellular bacteria to ensure that no contamination was present.
DNA Methods
Acanthamoeba DNA was extracted with the QiaAmp DNA mini kit (Qiagen) using a modified protocol. After 200 µL of suspended Acanthamoeba cells were subjected to 3 cycles of freezing in liquid nitrogen and thawing at 56°C, 20 µL of proteinase K and 200 µL of Buffer AL were added and, after vortexing, incubated at 56°C for 10 minutes. After incubation, 200 µL of 95% ethanol was added, and the sample was vortexed for 15 seconds, loaded onto the column, and washed according to the manufacturer's protocol. Purified DNA was eluted in 60 µL of Buffer AE. Extraction was confirmed by amplifying 18S Acanthamoeba DNA using real-time quantitative polymerase chain reaction (PCR). Then 5 µL of extracted DNA was added to a 20-µL solution of ×1 Taqman Universal Master Mix (Life Technologies) with 200 nmol/L each of primers TaqAcF1 and TaqAcR1 and probe TaqAcP1, amplified, and analyzed as described elsewhere [23, 24] .
Detection of Endosymbionts in Acanthamoeba spp.
Acanthamoeba DNA extractions were used as a template for amplifying any copurified endosymbiotic prokaryote 16S DNA. Each 25-µL PCR reaction consisted of 1U Native Taq DNA polymerase (Life Technologies), ×1 Buffer, 400 nmol/L each of primers 8FPL (5′-AGTTTGATCCTGGCTCAG-3′) and 806R (5′-GGACTACCAGGGTATCTAAT-3′), 200 µmol/ L dNTP, 1.5 nmol/L magnesium chloride, and 3 µL of extracted Acanthamoeba DNA. The mixture was incubated at 94°C for 5 minutes. Cycling conditions were as follows: 35 cycles of 45 seconds at 94°C, 30 seconds at 55°C, 1 minutes at 72°C, and finally a-10 minute incubation at 72°C. To detect potential endosymbionts belonging to the Chlamydiales, primers pan-Chlamydia forward and pan-Chlamydia reverse [25] were used to amplify the Acanthamoeba DNA extracts.
The 20-µL PCR reaction involved 10 µL of Amplitaq Gold Fast Mix (Applied Biosystems), 500 nmol/L each of primers panChlamydia forward (5′-CGTGGATGAGGCATGCRAGTC-3′) and pan-Chlamydia reverse (5′-GTCATCRGCCYYACCTTVSR CRYYTCT-3′), and 3 µL of extracted Acanthamoeba DNA. The mixture was incubated at 95°C for 10 minutes and cycled 40 times through 96°C for 5 seconds, 65°C for 5 seconds, and 68°C for 30 seconds. Finally, the solution was incubated at 72°C for 30 seconds. Amplified product was purified using the QIAquick gel extraction kit (Qiagen). For sequencing, 1 µL of purified product was added to 0.5 µL of BigDye v3.1 (Life Technologies), 1.5 µL of buffer, and 1 µL of the respective primer. 
30173
Human nasal swab sample Holosporaceae (Rickettsiales) Horn et al [7] , current report 50372 Soil Gast et al [20] 50495 Human cornea Mycobacterium spp. Gast et al [20] , current report A. culbertsoni 30171 Primary monkey kidney tissue culture . . . Culbertson [22] Acanthamoeba sp. PRA-220 Lake sediment Parachlamydia sp. OEW1a; Candidatus procabacter sp. OEW1
Heinz et al [6] , current report Abbreviation: ATCC, American Type Culture Collection.
The solution was incubated at 96°C for 1 minutes, then cycled 35 times at 96°C for 10 seconds, 50°C for 5 seconds, and 60°C for 4 minutes, cleaned using the BigDye X Terminator Purification Kit (Life Technologies), and analyzed with an ABI 3130xl genetic analyzer (Applied Biosystems). Sequences were aligned using BLASTN algorithm to identify the potential endosymbiont.
Acanthamoeba Infection of EpiCorneal Cells
Each EpiCorneal tissue (Cor-100-AFAB-; MatTek) sample was equilibrated in 6-well plates in 5 mL of Cor-100-MM-AFAB medium overnight at 37°C. Spent medium was recovered, and 5 mL of new medium was added to each well. Next, 4800
Acanthamoeba cells, either Acanthamoeba castellanii 50493 or Acanthamoeba polyphaga 50372, in 25 µL of 712 PYG medium with additives, were added to the apical corneal epithelial layer. Inoculated EpiCorneal tissue was then incubated at 37°C for 48 hours. Spent medium was harvested, and 5 mL of fresh Cor-100-MM-AFAB medium containing 4 µg/mL azithromycin, 2 µg/mL doxycycline, or no antimicrobials was added to each well. EpiCorneal tissue was then incubated at 37°C for 72 hours and spent medium was saved. Sham infections of EpiCorneal cells using medium only and medium supplemented with azithromycin or doxycycline as above, were used as controls on each panel. One replicate of each set was used for squash preparation and microscopy, and another was saved for Acanthamoeba PCR of pre-and postantibiotic tissues. The other replicate was prepared for fixation and hematoxylin-eosin (HE) staining to assess for CPE (ie, visible structural changes to EpiCorneal cells on inoculation with Acanthamoeba).
Inflammatory Biomarker Assessment
Spent medium, including that from control wells, was assessed for inflammatory mediators using the interleukin 1β/interleukin 1F2 Quantikine HS enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems), interleukin 6 (IL-6) Quantikine HS ELISA kit (R&D Systems), tumor necrosis factor (TNF) α Quantikine HS ELISA kit (R&D Systems), and copper-zinc (CuZn) superoxide dismutase (SOD) ELISA kit (Enzo Life Sciences) and read on a Synergy Plate Reader (BioTek Instruments). Concentrations were calculated according to a standard curve generated using absorbance readings and were converted into concentrations using Gen5 Data Analysis Software version 1.11.5 (BioTek Instruments). A mean and standard error of the 3 replicates were calculated. Cytokine production in the presence of Acanthamoeba castellanii 50493-infected EpiCorneal cells treated with antimicrobials. Enzyme-linked immunosorbent assays were used to determine the concentration of cytokines in spent medium: tumor necrosis factor (TNF) α (A), interleukin 1 (IL-1) (B), interleukin 6 (IL-6) (C), and copper-zinc (CuZn) superoxide dismutase (SOD) (D). Baseline spent medium was taken from the initially equilibrated cells. EpiCorneal cells were inoculated with A. castellanii 50493 or medium and incubated for 2 days, after which the medium was harvested. The medium-only EpiCorneal cells were incubated with new medium for another 3 days, whereas Acanthamoeba-infected EpiCorneal cells were incubated with new medium or azithromycin or doxycycline for another 3 days.
Squash Preparation
EpiCorneal tissue inserts were washed with phosphate-buffered saline (PBS), excised, and then washed twice more with PBS.
Membranes were bound to a microscope slide with Permount Mounting Media (Fisher Scientific) and compressed with a glass cover slip. Adhered tissue was stained with hematoxylin and visualized with standard light microscopy.
Histology
EpiCorneal tissue inserts were washed twice with PBS to ensure removal of all residual medium. Samples were then fixed overnight in 10% formalin at room temperature.
They were then transferred back to PBS and shipped to MatTek for membrane preparation and H&E staining. Prepared slides were returned and then observed under light microscopy.
Effect of Azithromycin and Doxycycline on Pure Cultures of Acanthamoeba spp.
Acanthamoeba spp. found to harbor endosymbionts were purely cultured, as described above, and then treated for 72 hours at 37 C with either 4 µg/mL azithromycin or 2 µg/mL doxycycline. Pure cultures were then assessed for viability by microscopy and inoculation into fresh culture medium. All Acanthamoeba strains were tested for their ability to induce CPE, as well as presence in spent tissues by PCR, which were used as a surrogate of successful infection. A squash preparation of EpiCorneal cells 5 days after inoculation by each Acanthamoeba strain revealed enhanced shedding, as shown by increased delineation of apical cornea cells (Figure 1 ). This shedding was not observed in controls inoculated only with sterile medium. Results of PCR for Acanthamoeba spp. were positive in corneal tissues harvested after inoculation of A. polyphaga 30173, A. polyphaga 50495, and Acanthamoeba sp. PRA-220 (the 3 strains known to contain endosymbionts as described above), both without antibiotics (control tissues) and after 72-hour treatment with azithromycin or doxycycline, all with comparable cycle threshold values. Acanthamoeba strains were also assessed for their ability to induce an inflammatory response after inoculation onto EpiCorneal cells, as indicated by increased TNF-α, interleukin 1 (IL-1), and IL-6 expression. However, only 2 of the ATCC strains, A. castellanii 50493 (Figure 2 ) and A. polyphaga 50372 (Figure 3) , could stimulate an inflammatory response within the 5-day infection time period. Compared with an uninoculated control, A. castellanii 50493 significantly increased expression of TNF-α (P = .01), IL-1 (P < .001), and IL-6 (P < .001). A. polyphaga 50372 also seemed to enhance expression of all 3 cytokines (ie, TNF-α, IL-1, and IL-6), but these increases were not statistically significant. Expression of interleukin 10, interleukin 12, and interferon γ in response to Acanthamoeba infection was also assessed, but the concentrations of these cytokines were too low to be detected with available conventional and high-sensitivity cytokine assays (data not shown). By day 5 after infection, the presence of A. castellanii 50493 CuZn SOD was significantly increased (P = .04). Although the presence of A. polyphaga 50372 at days 3 and 5 after infection also seemed to increase CuZn SOD detection, these increases were not significant (P = .07 and P = .41, respectively). 
Azithromycin and Doxycycline Attenuation of Inflammatory Cytokine Expression
Supplementation of medium with azithromycin during infection of EpiCorneal cells with A. castellanii 50493 significantly attenuated inflammatory expression of biomarkers, including TNF-α (P = .06) and IL-1 (P = .01), but the effect on IL-6 was nonsignificant (P = .07) (Figure 2 ). IL-6 expression was also attenuated after supplementation with doxycycline (P = .01), but TNF-α expression was not (P = .08). CuZn SOD detection, increased by A. castellanii 50493 inoculation, was nonsignificantly decreased with the addition of azithromycin (P = .09) or doxycycline (P = .74). Treatment of A. polyphaga 50372 with either azithromycin or doxycycline resulted in apparent decreased expression of TNF-α and IL-1, but these changes were not significant (Figure 3 ).
Azithromycin and Doxycycline Attenuation of CPE
Compared with a medium-only sham infection, addition of azithromycin or doxycycline had no effect on the EpiCorneal tissue ( Figure 4 ). In the presence of A. castellanii 50493, there was marked separation of basolateral cells from the synthetic basement membrane and enhanced apical shedding. Supplementation of azithromycin or doxycycline into the growth medium present during days 3-5 reduced this separation at the basolateral margin (Figure 4) . Infection with A. polyphaga 50372 did not seem to markedly affect cells at the basolateral margin. However, well-demarcated spherical structures resembling acanthamoebae were present at the margin of shedding cells, flanked by highly granulated epithelial cells that may have been responding to invasion. With addition of azithromycin, these spherical structures appeared less entrenched, and granularity of adjacent epithelial cells was almost absent (Figure 4 ). With addition of doxycycline, no spherical structures could be seen, and granularity was absent. Acanthamoebae remained viable after addition of antibiotics, as evidenced by their observed motility and subsequent ability to grow in fresh medium after treatment.
DISCUSSION
AK is a sight-threatening, emerging parasitic infection among contact lens users globally, one that causes significant morbidity due to prolonged courses of anti-amoebic therapy and frequent surgical intervention. Multistate outbreaks of AK have left many patients blind and led to both lawsuits against contact lens solution manufacturers and federal-level product recalls, all of which are costly at individual, public health, and economic levels. Because new and more efficacious treatments of AK are warranted, and because acanthamoebae are known to harbor potentially oculotropic bacterial endosymbionts, it seems reasonable to investigate such organisms as possible therapeutic targets, using well-tolerated, commercially available, and FDA-licensed antimicrobials. Using culturable strains of Acanthamoeba, we have demonstrated that EpiCorneal tissue inoculated with acanthamoebae serves as a model of clinical AK, and we have also illuminated the possible contribution of bacterial endosymbionts to the pathogenesis of AK. We confirmed the presence of bacterial endosymbionts in 2 ATCC strains, A. polyphaga 30173, possessing a Rickettsialeslike microbe and consistent with findings by Horn et al [7] , and Acanthamoeba sp PRA-220, containing Parachlamydia sp. OEW1 and Candidatus procabacter sp. OEW1, also detected by Heinz et al [6] . We also identified a novel endosymbiont in A. polyphaga 50495 belonging to Mycobacterium spp. Mycobacteria have been implicated in keratitis [27] , suggesting that these organisms harbor their own tropism and virulence against the cornea. The strain A. polyphaga 50495 is of corneal origin, indicating that it is well adapted to corneal infection; this trait may be due, at least partly, to its mycobacterial endosymbiont. Although we were unable to identify by 16S DNA amplification an endosymbiont in the 2 strains that were found to be most effective at infecting the 3-dimensional corneal model, we instead detected Pelamonas puraquae, a known contaminant of even highly purified water [26] . In the same way that Candidatus procabacter sp. OEW1 masked the detection of a second endosymbiont, Parachlamydia sp. OEW1 via 16S DNA amplification in Acanthamoeba sp. PRA-220, Pelamonas puraquae 16S DNA contamination could have obscured detection of bacterial endosymbionts present in the other Acanthamoeba strains that we tested in the EpiCorneal model.
Primers more specific to endosymbionts have been able to overcome the issue of competing DNA [6] ; however, owing to the considerable variety of potential endosymbionts, this approach is not well suited for excluding their presence. Other authors, including Michel et al [21] , have demonstrated that Acanthamoeba spp., such as A. castellanii 50739, are capable hosts of a wide range of potential endosymbionts, each with the possibility of enhancing host Acanthamoeba virulence. As such, the clinical consequence in AK of endosymbiosis is potentially far greater than the spectrum quantified here.
The EpiCorneal model has been validated to accurately represent the cornea over several days and a previous iteration of the model has been used to assess irritant damage to the cornea [13] . The model is limited by the absence of a full host immune system. However, the human cornea is immune privileged, and corneal cells themselves are known to have a prominent role in the immune response [28] . Moreover, the slow speed of Acanthamoeba infection may make the absence of the full immune system negligible in the short term, the first 5 days of infection. Altogether, the EpiCorneal model is probably superior in replicability and representation of human keratitis compared with the standard in situ animal eye models. With this model, we were able to observe CPE and detect enhanced inflammatory biomarker expression in response to infection by A. castellanii 50493 and A. polyphaga 50372. A hallmark of AK is the slow progression of infection [29] . As such, it is likely that the other Acanthamoeba strains would also have been able to induce detectable cytokine expression if allowed to infect for a longer duration. We were unable to detect interferon γ, interleukin 10, or interleukin 12, possibly owing to a dilutional effect of the high ratio of medium to cells required to sustain the EpiCorneal tissue.
SOD, an enzyme that degrades superoxide anion radicals, is up-regulated early in infection to mitigate increases in oxygen radicals [30] . Thus, it is a marker of the inflammatory impact of Acanthamoeba, a notably slow-manifesting infection. The isotype CuZn SOD is confined intracellularly in corneal epithelial cells, so detection should correlate with the degree of corneal epithelial cells lysis. Alternatively, increased detection could represent up-regulation in response to infection. Regardless, CuZn SOD concentration in spent medium should correlate with Acanthamoeba virulence. Indeed, by day 5 of infection with A. castellanii 50493, we noted increased expression of CuZn SOD.
There are several potential paradigms of how endosymbionts contribute to the virulence of acanthamoebae. Although endosymbiotic bacteria enhance inflammatory cytokine responses in AK, this does little to inform whether this paradigm favors Acanthamoeba virulence in vivo. If endosymbionts do little to enhance virulence, then the presence of their pathogen-associated molecular patterns (ie, those molecular moieties specific to endosymbiont classes and recognized by the innate immune system) could favor the host by further stimulating the immune system and promoting an effective anti-Acanthamoeba response. Alternatively, if endosymbionts sufficiently enhance virulence then the increased cytokine response is a marker of a more effective Acanthamoeba infection. Blackman et al [31] suggested that intracellular contents of acanthamoebae drive inflammation. Similarly, Illingworth and Cook [32] remarked that inflammation increases at the commencement of anti-acanthamoebal chemotherapy and suggested this was due to the release of intracellular antigens. These intracellular antigens, theoretically, could be endosymbionts normally concealed within acanthamoebae. Their presence could be responsible for increased inflammation and host damage during Acanthamoeba infection.
Some authors have argued that Acanthamoeba-associated cytotoxicity, observed in the context of granulomatous amoebic encephalitis, may result from an aggressive immune response rather than from direct Acanthamoeba virulence [33] . Interestingly, Acanthamoeba infection is generally observed where the immune response is hampered; granulomatous amoebic encephalitis and cutaneous acanthamoebiasis are usually observed in immunocompromised individuals [29] , and the cornea itself is immunoprivileged to prevent a vigorous immune response from disrupting the delicate transparent corneal architecture [34] . Even lacking virulence of their own, endosymbionts may serve to distract the immune system from developing an immune response optimized for invading Acanthamoeba.
Azithromycin has long been known for having immunomodulatory and anti-inflammatory effects in addition to antibacterial activity [35] . When oseltamivir therapy was augmented with azithromycin for the treatment of influenza, there was an earlier resolution of symptoms despite an absence of antiviral activity [36] . Doxycycline is approved as an anti-inflammatory in the treatment of rosacea [37] . Furthermore, 1 µL of 0.025% doxycycline solution decreased corneal shedding and inflammatory cytokine production in a dry-eye model [38] . However, 1 µL of balanced salt solution was also found to produce a similar reduction in shedding and inflammatory cytokines, indicating that reduced inflammation may be attributed to rehydration and not to anti-inflammatory effects of doxycycline.
In addition, in their assessment of drug susceptibilities of Parachlamydia acanthamoeba, Maurin and colleagues [39] noted that no concentration of tetracyclines or macrolides displayed toxic effects against the acanthamoebae themselves, and in vitro culture of Waddlia chondrophila is predicated on resistance of A. castellanii to both azithromycin and doxycycline, where amoebae remain viable until at least 7 days after antibiotic addition [40] . We also documented no loss of motility or viability of acanthamoebae in pure cultures treated with both antibiotics. Our biomarker and histopathologic data indicate that antimicrobials targeting intracellular bacteria, but lacking efficacy against Acanthamoeba spp. directly, are capable of attenuating inflammation and CPE secondary to Acanthamoeba infection.
Whether it is solely an anti-inflammatory effect of azithromycin and doxycycline or caused by attenuation or eradication of bacterial endosymbionts, the presence of these agents decreased inflammatory biomarker expression and CPE in a human corneal tissue model of AK. As such, they merit further investigation into their value as adjuvants to anti-acanthamoebic chemotherapy, which is limited by its poor efficacy and prolonged duration.
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